Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy

Cardiovascular and Interventional Radiology
Annemarie UhligJohannes Uhlig

Abstract

To evaluate survival of patients with localized T1a clear cell renal cell carcinoma (ccRCC) who received cryosurgery or thermal ablation compared to deferred therapy. We included 733 patients with histopathologically confirmed localized T1a ccRCC who either received cryosurgery (n = 315) or thermal ablation (n = 155), as well as patients who deferred therapy (n = 263) from the 2000-2013 Surveillance, Epidemiology, and End Results Program urinary cancer file. Cox proportional hazard models were used to compare cancer-specific survival (CSS) across subgroups. Sensitivity analyses were conducted to assess potential unmeasured confounding by comorbidities. Patients treated with cryosurgery and thermal ablation had a statistically significant CSS benefit compared to those who deferred therapy (cryosurgery HR 0.25, 95% CI 0.14-0.45, p < 0.001; thermal ablation HR 0.27, 95% CI 0.13-0.55, p < 0.001, after adjustment for age at diagnosis, tumor grade, and size). There was no significant difference in CSS comparing cryosurgery to thermal ablation (HR 1.03, 95% CI 0.45-2.3, p = 0.95, after adjustment for age at diagnosis, tumor grade, and size). These results proved robust upon sensitivity analyses: After adjustment for comorbidities with...Continue Reading

References

Aug 21, 2002·Medical Care·Carrie N KlabundeJulie M Legler
Apr 6, 2007·European Urology·Börje LjungbergUNKNOWN European Association of Urology Guideline Group for renal cell carcinoma
Dec 11, 2008·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Pierre I KarakiewiczJean-Jacques Patard
Aug 18, 2009·The Journal of Urology·Steven C CampbellUNKNOWN Practice Guidelines Committee of the American Urological Association
Nov 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexander KutikovRobert G Uzzo
Jun 7, 2011·Epidemiology·Tyler J VanderWeele
Sep 11, 2012·European Urology·Sarah P PsutkaDebra A Gervais
Apr 24, 2013·Nature Reviews. Urology·Arturo CastroRaymond J Leveillee
May 16, 2013·Cancer·Brian ShuchUNKNOWN Urologic Diseases in America Project
Jan 5, 2014·Cardiovascular and Interventional Radiology·Christos S Georgiades, Ron Rodriguez
Jun 17, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Hiten D PatelMohamad Ezzeddine Allaf
Aug 12, 2014·European Urology·R Houston ThompsonBradley C Leibovich
Nov 17, 2016·International Journal of Surgery·Emily F Kelly, Raymond J Leveillee

❮ Previous
Next ❯

Citations

Apr 27, 2018·Current Opinion in Urology·Jaime O Herrera-Caceres, Michael A S Jewett
Oct 12, 2018·Current Opinion in Urology·Laura SandbergenMaria Pilar Laguna
Dec 14, 2019·Minerva urologica e nefrologica = The Italian journal of urology and nephrology·J Patrick MershonNoah S Schenkman
Jun 10, 2020·Current Oncology Reports·Rand N Wilcox Vanden BergTimothy D McClure
May 22, 2019·Insights Into Imaging·B M AartsF M Gómez
Jul 4, 2018·Japanese Journal of Radiology·Takaaki HasegawaKoichiro Yamakado
May 22, 2021·European Journal of Radiology·Athina C TsiliUNKNOWN Oncologic Imaging Subcommittee Working Group of the Hellenic Radiological Society

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.